For the throat announcing its deal with whole foods will close on monday and immediately lower prices on staple good and prime members will get discounts news sent shockwaves throughout the market wiping out 23 billion in market cap in a matter of minutes. The list goes on and on. The nightmare future for retailers its here. Starts on monday what do you do as an investor in these name tonight i think it sets up not too differently in midjune when amazon announced they were buying whole foods you just talked about 22 billion in market cap. The stocks went back to where they were back to early june youll have some buying opportunities. Maybe a name like kroger its important to remember that whole foods combination with amazon while obviously prime is a huge differentiator for their Grocery Sales they are about less than 5 of u. S. Grocery sales. Kroger they have 120 billion in Grocery Sales last year, 120 billion. Thats 10 x of what kroger has investors are shooting first asking question
Needed drugs. They have not provided an analysis for how physicians would have to refer beneficiaries to more costly hospital outpatient settings. Cms has not indicated how will affect the beneficiary access and quality birth but during the course of a formal evaluation. Not surprisingly the proposed experiment has been one of the condemned by experts and stakeholders. Almost immediately after his proposed demonstration was release we received a letter from times from over 300 stakeholder organizations asking for help in getting cms to withdraw the proposal. These organizations include the arthritis foundation, the Caregiver Action Network the immune deficiency foundation, the lung cancer alliance, and the National Alliance for Mental Illness. The organizations that have reached out with concerns about how the proposal represents patients who suffer from the disease is treated by these drugs including cancer arthritis Mental Illness and hiv represent the physicians who treat the patien
Results of practices in rural areas like most of my state of iowa are the patients with a rare disease so what safeguards do you have with regard to treating patients served a smaller practices in rural areas with Rare Diseases . I share your commitment to a small and rural practice i grew up in a small town in texas with a 2 Family Practice we did propose to include rural and small practices but noted we were concerned and focused on the access issues and we sought common tiffany adjustments or exclusions or other changes were needed so we will assess those comments to determine if any adjustments are needed. Number two we have heard from a number of groups that many patients and providers could have been avoided the patients were included in the design at the front end wellplanned city put in and rare when faldo small practices of the stakeholders in the future . We proposed up process multi phase two that includes input of multiple points including patient input to were looking at c
The word imbusineeciles, referro members of congress. But no testimony. The leader of turing chemicals refused to testify today. The man known as pharmas bad boy for raising the price of an older drug by 500 cited his fifth amendment right against selfrecrimination. But as meg reports from capitol hill he was anything but silent. Reporter representatives from valiant pharmaceuticals, fda, and the pharmacy benefits manager industry group, were all invited to testify today at a congressional hearing on drug pricing. But the star witness was the infamous martin shkreli. His former company, turing pharmaceuticals, gained notoriety for hiking the price of a 62yearold drug by more than 5,000 . Shkreli is separately facing federal charges of securities fraud. He managed to steal the show while not answering any questions. I intend to follow the advice of my counsel, not yours are i invoke my fifth amendment privilege against selfincrimination and decline to answer your question. On advice of
The word imbusineeciles, referro members of congress. But no testimony. The leader of turing chemicals refused to testify today. The man known as pharmas bad boy for raising the price of an older drug by 500 cited his fifth amendment right against selfrecrimination. But as meg reports from capitol hill he was anything but silent. Reporter representatives from valiant pharmaceuticals, fda, and the pharmacy benefits manager industry group, were all invited to testify today at a congressional hearing on drug pricing. But the star witness was the infamous martin shkreli. His former company, turing pharmaceuticals, gained notoriety for hiking the price of a 62yearold drug by more than 5,000 . Shkreli is separately facing federal charges of securities fraud. He managed to steal the show while not answering any questions. I intend to follow the advice of my counsel, not yours are i invoke my fifth amendment privilege against selfincrimination and decline to answer your question. On advice of